Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
Stephen A. Harrison, Juan P. Frías, Guy Neff, Gary A. Abrams, K. Lucas, William Sánchez, Sudhanshu Gogia, Muhammed Y Sheikh, Cynthia Behling, Pierre Bédossa, Lan Shao, Doreen Chan, Erica Fong, Brittany de Temple, Reshma Shringarpure, Erik J. Tillman, Tim Rolph, Andrew Cheng, Kitty Yale
Topics & Concepts
MedicineSteatohepatitisPlaceboClinical endpointInternal medicineFatty liverGastroenterologyLiver biopsyFibrosisSurrogate endpointSteatosisBiopsySurgeryClinical trialPathologyDiseaseAlternative medicineFibroblast Growth Factor ResearchLiver Disease Diagnosis and TreatmentLiver physiology and pathology